Tissium was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. The company has made tremendous strides since it began.
Currently, the Company has a pipeline of seven products across three verticals, including sutureless nerve repair, hernia repair and cardiovascular sealants. Each product is designed to enhance the tissue reconstruction process in a unique way. In addition, the company develops complementary delivery and activation devices for enhanced performance and usability of its products.
Tissium's co-founder and Chief Innovation Officer, Maria Pereira spoke to Let's Talk Medtech about the company's success and many of the hurdles and challenges it was facing. You can listen to the conversation below.
